Artemisinin-Polypyrrole Conjugates: Synthesis, DNA Binding Studies and Preliminary Antiproliferative Evaluation
Greater than the sum of its parts: Artemisinins are currently in phase I–II clinical trials against breast, colorectal and non‐small‐cell lung cancers. In an attempt to offer increased specificity, a series of hybrid artemisinin–polypyrrole minor groove binder conjugates are described. DNA binding/m...
Saved in:
Published in | ChemMedChem Vol. 8; no. 5; pp. 709 - 718 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
01.05.2013
WILEY‐VCH Verlag Wiley Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Greater than the sum of its parts: Artemisinins are currently in phase I–II clinical trials against breast, colorectal and non‐small‐cell lung cancers. In an attempt to offer increased specificity, a series of hybrid artemisinin–polypyrrole minor groove binder conjugates are described. DNA binding/modelling studies and preliminary biological evaluation give insights into their mechanism of action and the potential of this strategy. |
---|---|
Bibliography: | British Engineering and Physical Sciences Research Council (EPSRC) ArticleID:CMDC201200536 istex:37E20EDCF83A0F3E2E2CEB27046CEBF02996E7C9 EU FP6 Malaria Initiative ANTIMAL ark:/67375/WNG-PX6STWLB-Q These authors contributed equally to this work. researchfish UKRI ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 1860-7179 1860-7187 |
DOI: | 10.1002/cmdc.201200536 |